Dana-Farber Cancer Institute, Inc. v. Bristol-Myers Squibb Company et al. > Summary
Court Case Number IPR2023-00249
Filing Date Dec 29, 2022
Institution Decision Date -
Decision Date Apr 10, 2023
Court Patent Trial and Appeal Board
Status Terminated-Settled
Administrative JudgesZhenyu Yang, Jeffrey N. Fredman, Erica A. Franklin
Judge Writing the Final DecisionZhenyu Yang
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Petitioner
Patent Owner
Petitioner Attorneys
5Dana-Farber Cancer Institute
Attorney Name: Amanda K. Antons
Dechert
Dana-Farber Cancer Institute
Attorney Name: Katherine A. Helm
Dechert
Dana-Farber Cancer Institute
Attorney Name: Noah M. Leibowitz
Dechert
Dana-Farber Cancer Institute
Attorney Name: Salma Jabbour
Dechert
Dana-Farber Cancer Institute
Attorney Name: Robert Paarlberg
Dechert
Patent Owner Attorneys
4Related Patents
Doc No | Title | Issue date |
---|---|---|
10323092 | Cancer immunotherapy by disrupting PD-1/PD-L1 signaling | Jun 18, 2019 |